Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation

Annals of Hematology

Volumn 81, Issue 1, 2002, Pages 11-15

  Sevilla, J ^a   Rodriguez A ^b   Hernandez Maraver D ^b   de Bustos, J G ^b   Aguado, M J ^b   Ojeda, E ^b   Arrieta, R ^b   Hernandez Navarro F ^b   La Paz, H U ^b  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b NONE   (Spain)

Author keywords

Hematopoietic transplantation; Myelodysplasia; Peripheral blood progenitor cell (PBPC); Secondary leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOKINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PROCARBAZINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RISK; CELL ISOLATION; CONTROLLED STUDY; DRUG DOSE REGIMEN; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INCIDENCE; LYMPHOMA; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MULTIPLE MYELOMA; MYELODYSPLASIA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL MOBILIZATION;

ACUTE DISEASE; ADULT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LEUKEMIA, MYELOID; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036942450     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-001-0400-0     Document Type: Article

References (17)

1. Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, et al. (1994) Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527-2534
2. Traweek ST, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman SJ (1994) Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 84:957-963
3. Pedersen-Bjergaard J, Pedersen M, Myhre J, Geisler C (1997) High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. Leukemia 11:4654-1660
4. Govindarajan R, Jagannath S, Flick JT, Vesole DH, Sawyer J, Barlogie B, et al. (1996) Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma. Br J Haematol 95:349-353
5. Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ (1994) Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 83:3780-3786
6. Amigo ML, del Cañizo MC, Rios A, Garcia MA, Caballero MD, Martín A, et al. (1999) Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS. Bone Marrow Transplant 23:997-1002
7. Taylor PARA, Jackson GH, Lennard AL, Hamilton PJ, Proctor SJ (1997) Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow. Leukemia 11: 1650-1653
8. Friedberg JW, Neuberg D, Stone RM, Alyea E, Jallow H, et al. (1999) Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 17:3128-3135
9. Krishnan A, Bhatia S, Slovak ML, Arber DA, Niland JC, Nademanee A, et al. (2000) Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 95:1588-1593
10. Pedersen-Bjergaard J, Andersen MK, Christiansen DH (2000) Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood 95:3273-3279
11. Bhatia S, Ramsay NKC, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ, et al. (1996) Malignant neoplasms following bone marrow transplantation. Blood 87:3633-3639
12. Perry AR, Peniket AJ, Watts MJ, Leverett D, Goldstone AH, Linch DC (1999) Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis. Br J Haematol 105:280-287
13. Hernández-Navarro F, Ojeda E, Arrieta R, et al. (1995) Single-centre experience of peripheral blood stem cell transplantation using cryopreservation by immersion in a methanol bath. Bone Marrow Transplant 16:71-77
14. Hernández-Navarro F, Ojeda E, Arrieta R, et al. (1998) Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases. Bone Marrow Transplant 21: 511-517
15. McMillan AK, Goldstone AH (1991) Autologous bone marrow transplantation for non-Hodgkin's lymphoma. Eur J Haematol 41:129-135
16. Tutschka PJ, Copelan EA, Klein JP (1987) Bone marrow transplantation for leukemia following a new busulphan and cyclophosphamide regimen. Blood 70:1382-1388
17. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199